These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 15602195
1. Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. Kalies H, Verstraeten T, Grote V, Meyer N, Siedler A, Schmitt HJ, Breuer T, Moulton LH, von Kries R, Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group. Pediatr Infect Dis J; 2004 Oct; 23(10):944-50. PubMed ID: 15602195 [Abstract] [Full Text] [Related]
2. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J. Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739 [Abstract] [Full Text] [Related]
3. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA, IMPACT Investigators, Waters V, Kandola K. Pediatr Infect Dis J; 2009 Jun; 28(6):521-8. PubMed ID: 19436236 [Abstract] [Full Text] [Related]
4. New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel). Johns TL, Hutter GE. Ann Pharmacother; 2010 Mar; 44(3):515-23. PubMed ID: 20197476 [Abstract] [Full Text] [Related]
5. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O. Hum Vaccin Immunother; 2014 Mar; 10(10):2795-8. PubMed ID: 25483640 [Abstract] [Full Text] [Related]
6. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R. Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487 [Abstract] [Full Text] [Related]
7. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa). Dhillon S. BioDrugs; 2010 Oct 01; 24(5):299-302. PubMed ID: 20795752 [Abstract] [Full Text] [Related]
8. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants. Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E. Int J Infect Dis; 2007 Mar 01; 11(2):129-36. PubMed ID: 16762579 [Abstract] [Full Text] [Related]
9. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid. Bernstein HH, Seyferth ER. Vaccine; 2017 Dec 04; 35(48 Pt B):6707-6711. PubMed ID: 29054729 [Abstract] [Full Text] [Related]
10. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model. Mawas F, Newman G, Burns S, Corbel MJ. J Infect Dis; 2005 Jan 01; 191(1):58-64. PubMed ID: 15593004 [Abstract] [Full Text] [Related]
11. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L. Pediatrics; 1999 Jan 01; 103(1):25-30. PubMed ID: 9917435 [Abstract] [Full Text] [Related]
12. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants. Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM. Pediatr Infect Dis J; 1998 Apr 01; 17(4):294-304. PubMed ID: 9576383 [Abstract] [Full Text] [Related]
13. Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers. Halperin SA, Tapiero B, Law B, Diaz-Mitoma F, Duval B, Langley JM, Elrick DB, Jacquet JM. Vaccine; 2006 May 01; 24(18):4017-23. PubMed ID: 16516357 [Abstract] [Full Text] [Related]
14. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey. Yüksel N, Beyazova U, Balci IF, Aksakal FN, Camurdan AD, Sahin F, Rota S. Int J Infect Dis; 2012 May 01; 16(5):e354-7. PubMed ID: 22387144 [Abstract] [Full Text] [Related]
15. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ, 085 Study Investigators. J Pediatr; 2007 Jul 01; 151(1):43-9, 49.e1-2. PubMed ID: 17586189 [Abstract] [Full Text] [Related]
16. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine. Langley JM, Predy G, Guasparini R, Law B, Diaz-Mitoma F, Whitstitt P, Tapiero B, Dionne M, Tomovici A, Mills E, Halperin SA. Vaccine; 2007 Jan 22; 25(6):1121-5. PubMed ID: 17045366 [Abstract] [Full Text] [Related]
18. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. Denoël PA, Goldblatt D, de Vleeschauwer I, Jacquet JM, Pichichero ME, Poolman JT. Clin Vaccine Immunol; 2007 Oct 22; 14(10):1362-9. PubMed ID: 17699836 [Abstract] [Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age. Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M. Pediatr Infect Dis J; 2011 Sep 22; 30(9):e164-9. PubMed ID: 21494175 [Abstract] [Full Text] [Related]
20. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007. Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R. Pediatr Infect Dis J; 2008 Aug 22; 27(8):755-7. PubMed ID: 18594482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]